Viewing Study NCT04213118


Ignite Creation Date: 2025-12-25 @ 4:41 AM
Ignite Modification Date: 2025-12-26 @ 3:43 AM
Study NCT ID: NCT04213118
Status: UNKNOWN
Last Update Posted: 2023-01-17
First Post: 2019-12-25
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Anlotinib Combined With TACE in Hepatocellular Carcinoma Patients at High Risk of Post Surgery Recurrence
Sponsor: First Affiliated Hospital Xi'an Jiaotong University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module